- Aurora Cannabis reports £20.42 million of adjusted EBITDA loss in Q4.
- The cannabis producer says its revenue slid 5% in the fourth quarter.
- Aurora Cannabis posts £1.95 billion of full-year loss on Tuesday.
Aurora Cannabis Inc. (TSE: ACB) published its earnings report on Tuesday after the bell, that highlighted the company to have missed estimates for revenue in the fiscal fourth quarter. According to the Edmonton-based company:
“Total volume of dried consumer cannabis sold increased by 36%, but was offset by a 30% decrease in the average net selling price per gram of consumer cannabis as the Company’s value segment brand, Daily Special, accounted for a greater percentage of consumer cannabis net revenue, at 62% of flower revenue compared to 35% in the prior quarter.”
Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.
Aurora says its revenue slid 5% in the fourth quarter
Aurora reported £42.56 million of revenue in the fourth quarter that represents a 5% annualised decline. On an adjusted basis, the company posted £20.42 million of EBITDA loss in Q4. In comparison, analysts predicted Aurora to print a slightly higher £43.21 million of revenue in the recent quarter and 38.96 pence of loss per share, as per FactSet.
The Canadian company said that sales were likely to take a hit in the fiscal first quarter. Aurora estimates to generate £35.41 million to £37.78 million of net sales in Q1. In its report published in May, Aurora had revealed its adjusted loss to have contracted to £29.66 million in Q3.
The financial results came only weeks after the licensed cannabis producer named Miguel Martin as its new CEO. Martin replaced Michael Singer who has been serving as an interim CEO since February.
Aurora Cannabis’ full-year loss widens to £1.95 billion
Aurora Cannabis said on Tuesday that it concluded the fiscal year with £1.95 billion of loss versus a sharply lower £171.64 million in the previous financial year. Its annual sales recorded a year over year growth of 13.6% from £144.90 million last year to £164.62 million in fiscal 2020.
Shares of the company were reported about 10% down in extended trading on Tuesday. Aurora Cannabis is now trading at £5.74 per share versus £18.63 per share at the start of 2020. The stock printed a year to date low of £4.89 per share in mid-May. Interesting in investing in the stock market online? Here’s a simple guide to get you started.
Aurora Cannabis performed fairly dovish in the stock market last year with an annual decline of more than 60%. At the time of writing, the Canadian licensed cannabis producer has a market cap of £650 million.